What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view.
Axillary dissection
Breast cancer
Micrometastasis
Primary systemic treatment
Sentinel lymph node biopsy
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
17
10
2020
revised:
17
11
2020
accepted:
21
12
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
26
1
2021
Statut:
epublish
Résumé
In 2020, the American Society of Clinical Oncology (ASCO) annual meeting was held as a virtual conference. Overall, 461 abstracts focused on breast cancer management. As European Breast Cancer Association of Surgical Trialists (EUBREAST) we summarize and comment the results of these abstracts dealing with axillary management in breast cancer patients and offer an interpretation on how these findings may be incorporated into clinical practice and further research.
Identifiants
pubmed: 33490932
doi: 10.1016/j.eclinm.2020.100708
pii: S2589-5370(20)30452-1
pmc: PMC7811045
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100708Informations de copyright
© 2020 The Author(s).
Déclaration de conflit d'intérêts
The authors declare no conflict of interest related to this paper